NSP · Insperity, Inc · Stock research

XMTR

Xometry, Inc.

AI-native manufacturing marketplace re-rating on a profitability inflection Q1 marketplace revenue +40% YoY, FY guide raised, Siemens embed plus ~$50M stock buy. Wedbush 7/16 Outperform $126 reopens Street upside above spot after June's above-cluster trade; the ~2026-08-06 Q2 print is the next binary.

ARCB

ArcBest Corporation

LTL-recovery narrative is maturing and now fighting a company crack: ArcBest's July 16 restructuring 2% headcount cut, $76.5M impairment, brand simplification signals the freight-cycle upturn hasn't reached its own P&L, with the July 29 Q2 print the binary that resolves self-help vs demand miss.

QCOM

QUALCOMM Incorporated

The data-center re-rating already failed: QCOM spiked to a 52-week high of $259.92 on the ~2026-06-24 Investor Day $15B-by-2029 guide, then gave back ~34% in 17 sessions to $171.78 as Hold downgrades and Apple modem-attrition math reasserted. Price is in a confirmed downtrend into a 2026-07-29 print that must quantify data-center bookings against a shrinking Apple line.

ALKS

Alkermes plc

Orexin (OX2R) re-rate has moved from discovery to consensus: 2026-07-13 long-term extension data confirmed durable wakefulness and Needham lifted PT to $62, but JPMorgan reinstated Neutral at $60 as spot presses the $56–62 target band. Sell-side has caught up; the tape is extended and catalyst-light into the ~early-August Q2 print, favoring a pullback to the $42 shelf over a chase. Next true binary is the Q4 idiopathic-hypersomnia readout.